Paramount BioCapital Asset Management

Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Industries / Tags:

Detailed Paramount BioCapital Asset Management Information

Geographic Data

Paramount BioCapital Asset Management headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Paramount BioSciences is a global pharmaceutical development and healthcare investment firm that conceives, nurtures, and supports new biotechnology and life-sciences companies. The company has a keen eye for finding and developing novel therapeutic medicines that have, in our opinion, significant market potential. It assesses promising drug candidates from around the globe, from academic centers to biotechnology firms to pharmaceutical companies. Once compounds are in-licensed, selected members of the Paramount BioSciences Executive Team -- each member has significant life sciences industry experience, as described in their bios -- supported by approximately 80 in-house professionals, manages their entire development cycle, supporting all aspects of drug development including manufacturing, formulation, technology transfer, pharmacology, toxicology, clinical development, regulatory, quality assurance, commercialization, and life cycle management. After technologies are in-licensed and management teams are recruited to run portfolio companies built around novel therapeutics, Paramount BioSciences arranges for financing through its affiliate Paramount BioCapital, Inc., a FINRA registered broker-dealer. The affiliate’s financial professionals have experience with securities and corporate transactions, including financings and mergers and acquisitions.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
4/2007 Innovive Pharmaceuticals Venture Round 15M
1/2005 Chelsea Therapeutics International Post-IPO Equity 14.5M
8/2009 CEL-SCI Post-IPO Equity 0
6/2006 Genelabs Technologies Venture Round 8.3M
5/2006 Alaunos Therapeutics Post-IPO Equity 0
8/2009 CEL-SCI Post-IPO Equity 0
4/2007 Innovive Pharmaceuticals Venture Round 0
6/2006 Genelabs Technologies Venture Round 0
5/2006 Alaunos Therapeutics Post-IPO Equity 0
1/2005 Chelsea Therapeutics International Post-IPO Equity 0
Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research